Q2 2021 Holdings
Filed 2021-08-10 | 62 holdings | $14.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.9M | 199,400 | 34.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.2M | 12,100 | 29.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $1.2M | 45,114 | 8.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.2M | 15,000 | 8.2% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.1M | 50,000 | 7.8% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $379.0K | 100,000 | 2.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $316.0K | 20,000 | 2.2% |
| Aziyo Biologics Inc(ELUT) | COM | 05479K106 | $288.0K | 30,000 | 2.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $246.0K | 9,000 | 1.8% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $198.0K | 10,000 | 1.4% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $53.2K | 796,106 | 0.4% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $18.0K | 2,232,857 | 0.1% |
| Biodesix Inc | COM | 09075X108 | $14.6K | 1,104,953 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.8K | 80,200 | 0.1% |
| Quidel Corp | COM | 74838J101 | $7.6K | 59,684 | 0.1% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $3.9K | 111,000 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $3.4K | 314,143 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $3.2K | 18,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $2.4K | 230,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $2.4K | 74,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $2.3K | 18,672 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $1.9K | 8,000 | 0.0% |
| Angion Biomedica Corp | COM | 03476J107 | $1.9K | 60,615 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $1.7K | 80,000 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $1.7K | 180,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $1.6K | 30,247 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $1.5K | 22,000 | 0.0% |
| Continental Resources Inc(CLRUSD) | COM | 212015101 | $1.5K | 38,600 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $1.3K | 300,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $1.3K | 190,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.2K | 72,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.2K | 50,000 | 0.0% |
| Equitrans Midstream Corporatio(ETRNUSD) | COM | 294600101 | $1.1K | 133,050 | 0.0% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $1.1K | 34,200 | 0.0% |
| Soleno Therapeutics Inc | COM | 834203101 | $1.0K | 876,899 | 0.0% |
| Biohaven Pharmaceutical Holding Co LTD(BHVN) | COM | G11196105 | $971 | 10,000 | 0.0% |
| Progenity Inc | COM | 74319F107 | $964 | 270,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $958 | 40,000 | 0.0% |
| Progyny Inc(PGNY) | COM | 74340E103 | $885 | 15,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $880 | 200,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $878 | 40,000 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $826 | 30,000 | 0.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $653 | 7,000 | 0.0% |
| Turning Point Therapeutics Inc | COM | 90041T108 | $624 | 8,000 | 0.0% |
| Pioneer Natural Resources Co(PXDEUR) | COM | 723787107 | $618 | 3,800 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $582 | 15,000 | 0.0% |
| Aspira Womens Health Inc | COM | 04537Y109 | $579 | 103,104 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $506 | 8,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $505 | 15,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $449 | 10,000 | 0.0% |